Cited by 80Pancreatic and Hepatic Oncology ResearchPancreatic function and diabetesCancer Genomics and Diagnostics

Loss of Pten and activation of kras synergistically induce formation of intraductal papillary mucinous neoplasia from pancreatic ductal cells in mice

Open access
Kopp, Janel L., Dubois, Claire L., Schaeffer, David F., Samani, Atefeh, Taghizadeh, Farnaz, Cowan, Robert W., Rhim, Andrew D., Stiles, Bangyan L. +2 more·2018·Gastroenterology

Abstract

Background & aims Intraductal papillary mucinous neoplasias (IPMNs) are precancerous cystic lesions that can develop into pancreatic ductal adenocarcinomas (PDACs). These large macroscopic lesions are frequently detected during medical imaging, but it is unclear how they form or progress to PDAC. We aimed to identify cells that form IPMNs and mutations that promote IPMN development and progression.Methods We generated mice with disruption of Pten specifically in ductal cells (Sox9CreER T2;Pten flox/flox;R26R YFP or Pten ΔDuct/ΔDuct mice) and used Pten ΔDuct/+ and Pten+/+ mice as controls. We also generated Kras G12D;Pten ΔDuct/ΔDuct and Kras G12D;Pten ΔDuct/+ mice. Pancreata were collected when mice were 28 weeks to 14.5 months old and analyzed by histology, immunohistochemistry, and electron microscopy. We performed multiplexed droplet digital polymerase chain reaction to detect spontaneous Kras mutations in Pten ΔDuct/ΔDuct mice and study the effects of Ras pathway activation on initiation and progression of IPMNs. We obtained 2 pancreatic sections from a patient with an invasive pancreatobiliary IPMN and analyzed the regions with and without the invasive IPMN (control tissue) by immunohistochemistry.Results Mice with ductal cell-specific disruption of Pten but not control mice developed sporadic, macroscopic, intraductal papillary lesions with histologic and molecular features of human IPMNs. Pten ΔDuct/ΔDuct mice developed IPMNs of several subtypes. In Pten ΔDuct/ΔDuct mice, 31.5% of IPMNs became invasive; invasion was associated with spontaneous mutations in Kras. Kras G12D;Pten ΔDuct/ΔDuct mice all developed invasive IPMNs within 1 month. In Kras G12D;Pten ΔDuct/+ mice, 70% developed IPMN, predominately of the pancreatobiliary subtype, and 63.3% developed PDAC. In all models, IPMNs and PDAC expressed the duct-specific lineage tracing marker yellow fluorescent protein. In immunohistochemical analyses, we found that the invasive human pancreatobiliary IPMN tissue had lower levels of PTEN and increased levels of phosphorylated (activated) ERK compared with healthy pancreatic tissue.Conclusions In analyses of mice with ductal cell-specific disruption of Pten, with or without activated Kras, we found evidence for a ductal cell origin of IPMNs. We also showed that PTEN loss and activated Kras have synergistic effects in promoting development of IPMN and progression to PDAC.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2017.12.007

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Combining oncogenic KRAS expression in the adult ductal lineage with Pten loss leads to IPMN formation in mice.

    “Combining oncogenic KRAS expression in the adult-ductal lineage with Pten loss leads to the formation of IPMNs124”

    From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [124]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kopp, J. L., Dubois, C. L., Schaeffer, D. F., Samani, A., Taghizadeh, F., Cowan, R. W., Rhim, A. D., Stiles, B. L., Valasek, M., & Sander, M.
Affiliations
  • University of British Columbia (CA)
  • University of California San Diego (US)
  • The University of Texas MD Anderson Cancer Center (US)
  • University of Southern California (US)
Corresponding author
Sander, Maike
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2018-04
Volume
154
Issue
5
Pages
1509-1523.e5
ISSN
0016-5085 (ISSN-L)
OpenAlex
W2779623685
Cited by
80
References
32
Citations by year
2026: 2 · 2025: 6 · 2024: 8 · 2023: 9 · 2022: 6 · 2021: 17 · 2020: 12 · 2019: 13 · 2018: 7
FWCI
3.86
Type
journal article
Language
en
Open access
Locations
  • Gastroenterology (acceptedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
National Institutes of Health (R01DK078803, R21CA194839)
Topics
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Keywords
intraductal papillary mucinous neoplasm, pancreatic ductal adenocarcinoma, PTEN, KRAS G12D, pancreatic ductal cells, pancreatic cysts, tumor progression, pancreatic cancer initiation, pancreatic intraepithelial neoplasia, RAS pathway activation
MeSH terms
Animals, Cell Movement, Cell Transformation, Neoplastic, Humans, Mice, Inbred C57BL, Mutation, Neoplasm Invasiveness, Pancreatic Ducts, Pancreatic Neoplasms, Phenotype, Time Factors, Signal Transduction, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Proto-Oncogene Proteins p21(ras), Neoplasms, Cystic, Mucinous, and Serous, Mice, Knockout, Disease Progression, Cell Lineage, Genetic Predisposition to Disease, Carcinoma, Pancreatic Ductal, Cell Proliferation, PTEN Phosphohydrolase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review